Benzinga's Top Pre-Market Losers

Ariad Pharmaceuticals (NASDAQ: ARIA) dipped 56.83% to $7.40 in the pre-market session after the company reported that it is pausing patient enrollment in studies of Iclusig.

CytRx (NASDAQ: CYTR) dipped 18.25% to $2.24 after the company priced its underwritten public offering of 10.0 million shares of common stock at a price of $2.25 per share.

Lexicon Pharmaceuticals (NASDAQ: LXRX) shares fell 7.75% to $2.50 in the pre-market trading after the company reported top-line results from a pilot study exploring the use of telotristat etiprate in ulcerative colitis.

Yum! Brands (NYSE: YUM) shares dropped 6.38% to $66.75 in pre-market trading after the company reported a 68% drop in its third-quarter profit and lowered its forecast.